The product was earlier approved and granted interchangeable designation byt he US Food and Drug Administration (USFDA) in May 2024, allowing substitution at the pharmacy level in accordance with state laws, Biocon said.
The product was earlier approved and granted interchangeable designation byt he US Food and Drug Administration (USFDA) in May 2024, allowing substitution at the pharmacy level in accordance with state laws, Biocon said.